FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Thomas Brandon
   2. Issuer Name and Ticker or Trading Symbol
ENVESTNET, INC. [ENV] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Investment Officer
(Last)
(First)
(Middle)
35 EAST WACKER DRIVE, SUITE 2400		 3. Date of Earliest Transaction (Month/Day/Year)
10/21/2020
(Street)

CHICAGO, IL 60601		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/21/2020   M(1)   10,000 A $ 12.55 278,701 D  
Common Stock 10/21/2020   S   7,200 D $ 81.37 (2) 271,501 D  
Common Stock 10/21/2020   S   1,700 D $ 82.11 (3) 269,801 D  
Common Stock 10/21/2020   S   1,100 D $ 82.92 (4) 268,701 D  
Common Stock 10/21/2020   M(1)   7,647 A $ 12.45 276,348 D  
Common Stock 10/21/2020   S   5,246 D $ 81.35 (5) 271,102 D  
Common Stock 10/21/2020   S   1,701 D $ 82.04 (6) 269,401 D  
Common Stock 10/21/2020   S   700 D $ 82.9 (7) 268,701 D  
Common Stock 10/21/2020   M(1)   8,000 A $ 15.34 276,701 D  
Common Stock 10/21/2020   S   5,391 D $ 81.37 (5) 271,310 D  
Common Stock 10/21/2020   S   1,609 D $ 81.99 (8) 269,701 D  
Common Stock 10/21/2020   S   1,000 D $ 82.92 (9) 268,701 D  
Common Stock 10/21/2020   M(1)   6,200 A $ 41.84 274,901 D  
Common Stock 10/21/2020   S   4,400 D $ 81.37 (10) 270,501 D  
Common Stock 10/21/2020   S   1,200 D $ 82.2 (11) 269,301 D  
Common Stock 10/21/2020   S   600 D $ 82.92 (12) 268,701 D  
Common Stock 10/21/2020   M(1)   4,800 A $ 53.88 273,501 D  
Common Stock 10/21/2020   S   3,274 D $ 81.38 (13) 270,227 D  
Common Stock 10/21/2020   S   1,226 D $ 82.12 (14) 269,001 D  
Common Stock 10/21/2020   S   300 D $ 82.93 (15) 268,701 D  
Common Stock 10/21/2020   M(1)   2,464 A $ 20.51 271,165 D  
Common Stock 10/21/2020   S   1,864 D $ 81.42 (16) 269,301 D  
Common Stock 10/21/2020   S   600 D $ 82.41 (17) 268,701 D  
Common Stock 10/21/2020   M(1)   1,690 A $ 31.7 270,391 D  
Common Stock 10/21/2020   S   1,490 D $ 81.47 (18) 268,901 D  
Common Stock 10/21/2020   S   200 D $ 82.73 (19) 268,701 D  
Common Stock               13,938 I See footnote (20)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $ 12.55 10/21/2020   M(1)     10,000 02/28/2012(21) 02/28/2021 Common Stock 10,000.00 $ 0 0 D  
Employee Stock Option (Right to Buy) $ 12.45 10/21/2020   M(1)     7,647 02/28/2013(22) 02/28/2022 Common Stock 7,647.00 $ 0 0 D  
Employee Stock Option (Right to Buy) $ 15.34 10/21/2020   M(1)     8,000 02/28/2014(23) 02/28/2023 Common Stock 8,000.00 $ 0 0 D  
Employee Stock Option (Right to Buy) $ 41.84 10/21/2020   M(1)     6,200 02/28/2015(24) 02/28/2024 Common Stock 6,200.00 $ 0 0 D  
Employee Stock Option (Right to Buy) $ 53.88 10/21/2020   M(1)     4,800 02/29/2016(25) 02/28/2025 Common Stock 4,800.00 $ 0 0 D  
Employee Stock Option (Right to Buy) $ 20.51 10/21/2020   M(1)     2,464 02/28/2017(26) 02/28/2026 Common Stock 2,464.00 $ 0 0 D  
Employee Stock Option (Right to Buy) $ 31.70 10/21/2020   M(1)     1,690 03/28/2018(26) 03/28/2027 Common Stock 1,690.00 $ 0 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Thomas Brandon
35 EAST WACKER DRIVE
SUITE 2400
CHICAGO, IL 60601		       Chief Investment Officer  

Signatures

 /s/ Shelly O'Brien, by Power-of-Attorney for Brandon Thomas   10/23/2020
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Reflects the cashless exercise of stock options which were granted pursuant to Rule 16b-3. The sale was pursuant to a Rule 10b5-1 plan that covers the cashless exercise and sale of stock options prior to their expiration date.
(2) The Common Shares reported herein as being sold were sold at a range of between $80.77 and $81.765 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(3) The Common Shares reported herein as being sold were sold at a range of between $81.79 and $82.77 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(4) The Common Shares reported herein as being sold were sold at a range of between $82.89 and $83.00 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(5) The Common Shares reported herein as being sold were sold at a range of between $80.75 and $81.75 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(6) The Common Shares reported herein as being sold were sold at a range of between $81.78 and $82.71 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(7) The Common Shares reported herein as being sold were sold at a range of between $82.785 and $82.97 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(8) The Common Shares reported herein as being sold were sold at a range of between $81.75 and $82.74 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(9) The Common Shares reported herein as being sold were sold at a range of between $82.76 and $83.02 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(10) The Common Shares reported herein as being sold were sold at a range of between $80.865 and $81.79 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(11) The Common Shares reported herein as being sold were sold at a range of between $81.89 and $82.88 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(12) The Common Shares reported herein as being sold were sold at a range of between $82.90 and $82.97 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(13) The Common Shares reported herein as being sold were sold at a range of between $80.865 and $81.85 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(14) The Common Shares reported herein as being sold were sold at a range of between $81.89 and $82.56 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(15) The Common Shares reported herein as being sold were sold at a range of between $82.905 and $82.97 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(16) The Common Shares reported herein as being sold were sold at a range of between $80.965 and $81.915 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(17) The Common Shares reported herein as being sold were sold at a range of between $81.975 and $82.905 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(18) The Common Shares reported herein as being sold were sold at a range of between $80.94 and $81.92 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(19) The Common Shares reported herein as being sold were sold at a range of between $82.56 and $82.905 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
(20) Represents shares held by a trust in which Mr. Thomas is the trustee.
(21) Original option grant vested in three installments beginning on the first date of grant and thereafter on the first anniversary of the date of grant as listed in the "Date Exercisable" column.
(22) Original option grant vested in three installments beginning on the first date of grant and thereafter on the first anniversary of the date of grant as listed in the "Date Exercisable" column.
(23) Original option grant vested in three installments beginning on the first date of grant and thereafter on the first anniversary of the date of grant as listed in the "Date Exercisable" column.
(24) Original option grant vested in three installments beginning on the first date of grant and thereafter on the first anniversary of the date of grant as listed in the "Date Exercisable" column.
(25) Original option grant vested in three installments beginning on the first date of grant and thereafter on the first anniversary of the date of grant as listed in the "Date Exercisable" column.
(26) Represents restricted stock units that vest over a 3-year period; one-third of the total amount vests on the first anniversary of the date of the grant of restricted stock units and then one-twelfth of the total amount vests on each three-month anniversary of the date of grant thereafter. These restricted stock units convert into common stock on a one-for-one basis.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.